Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: A case report and literature review

Renal Failure

Volumn 31, Issue 8, 2009, Pages 745-748

  Dobre, Mirela ^a   Wish, Jay ^b   Negrea, Lavinia ^b  

^a Huron Hospital   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

ANCA; Anti histone; Glomerulonephritis; Hydralazine; Pauciimmune

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; CYCLOPHOSPHAMIDE; DIGOXIN; HYDRALAZINE; ISOSORBIDE MONONITRATE; LISINOPRIL; METOPROLOL SUCCINATE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; TORASEMIDE;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; ERYTHROCYTE; FEMALE; HEMOPTYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNE COMPLEX NEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; LUNG AUSCULTATION; LUNG HEMORRHAGE; LUNG NODULE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; URINALYSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIHYPERTENSIVE AGENTS; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYDRALAZINE; HYPERTENSION;

EID: 70350652026     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903118590     Document Type: Article

References (16)

1. Nassberger L, Johansson AC, Bjorck S, Sjoholm AG. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: Autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med. 1991;229(3):261-265.
2. Peacock A, Weatherall D. Hydralazine-induced necrotizing vasculitis. BMJ. 1981;282:1121-1122.
3. Almroth G, Enestrom S, Hed J, Samuelsson I, Sjostrom P. Autoantibodies to leucocyte antigens in hydralazineassociated nephritis. J Intern Med. 1992;231(1):37-42.
4. Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol. 1994;33(2):109-114.
5. Choi HK, Merkel PA, Walker AM, Niles JL. Drugassociated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43(2):405-413.
6. Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. Q J Med. 1995;88:775-783.
7. Savige J, Davies D, Falk RJ, Jennette CJ, Wiik A. Antineutrophil cytoplasmatic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney International. 2000;57:846-862.
8. Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug- induced vasculitis. Ann Pharmacother. 2002;36:130-147.
9. Hess E. Drug-induced lupus. N Engl J Med. 1988;318:1460.
10. Speirs C, Fielder AH, Chapel H, Davey NJ, Batchelor JR. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus. Lancet. 1989;1(8644):922-924.
11. Batchelor JR, Welsh KI, Tinoco RM, et al. Hydralazineinduced systemic lupus erythematosus: Influence of HLADR and sex on susceptibility. Lancet. 1980;1(8178): 1107-1109.
12. Ihle BU, Whitworth JA, Dowling JP, Kincaid-Smith P. Hydralazine- associated glomerulonephritis. Clin Nephrol. 1984;22:230-238.
13. Merkel PA. Drugs associated with vasculitis. Curr Opin Rheumatol. 1998;10(1):45-50.
14. Nassberger L, Sjoholm AG, Jonsson H, et al. Autoantibodies against netrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol. 1990;81:380.
15. Ohtani H, Wakui H, Komatsuda A, et al. Differences between myeloperoxidase-specific and nonspecific P-ANCA-associated renal disease. Ren Fail. 2007; 29(2):183-187.
16. Burlingame RW, Rubin RL. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 1991; 88(2):680-690.